A phase II randomised controlled trial of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease (PD COMM)

Deeks, Jon (Principal Investigator)
Clarke, C E (Co-Investigator)
Rowland, Natalie (Co-Investigator)
Rick, Caroline (Co-Investigator)
Wheatley, Keith (Co-Investigator)

Short title	A phase II randomised controlled trial of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease (PD COMM)
Status	Finished
Effective start/end date	1/07/12 → 30/06/15

Funding

THE DUNHILL MEDICAL TRUST

1 Article

Lee Silverman voice treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial
Scobie, S., Jowett, S., Lambe, T., Patel, S., Woolley, R., Rowland, N., Rick, C., Smith, C., Brady, M., Clarke, C. E. & Sackley, C., 9 Aug 2021, In: Pilot and Feasibility Studies. 7, 1, 11 p., 154.
Research output: Contribution to journal › Article › peer-review

Open Access
File
179 Downloads (Pure)